Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T H Jacobsson, Robin Christensen, Philip J Mease, Henning Bliddal, Pierre Geborek
Dyk ned i forskningsemnerne om 'Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden'. Sammen danner de et unikt fingeraftryk.